CVE-2026-18235

CVE-2026-18235 is a high-severity vulnerability in Ibm I with a CVSS 3.x base score of 8.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote authenticated attacker to execute arbitrary Control Language commands due to insufficient input validation.

Frequently asked questions

What is CVE-2026-18235?
IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote authenticated attacker to execute arbitrary Control Language commands due to insufficient input validation.
How severe is CVE-2026-18235?
CVE-2026-18235 has a CVSS 3.x base score of 8.3, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability low.
Is CVE-2026-18235 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (24th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-18235?
CVE-2026-18235 affects Ibm I. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-18235?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-18235 published?
CVE-2026-18235 was published on 2026-08-12 and last updated on 2026-08-13.

References

Affected products (1)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →